Glial Cell Line-Derived Neurotrophic Factor

The founding member of the glial cell line-derived neurotrophic factor family. It was originally characterized as a NERVE GROWTH FACTOR promoting the survival of MIDBRAIN dopaminergic NEURONS, and it has been studied as a potential treatment for PARKINSON DISEASE.

Also Known As:

GDNF; GDNF Growth Factor; Glial Cell-Line Derived Neurotrophic Factor; Factor, Glial-Derived Neurotrophic; Glial Cell Derived Neurotrophic Factor; Glial Cell Line Derived Neurotrophic Factor; Glial Derived Neurotrophic Factor; Growth Factor, GDNF; Neurotrophic Factor, Glial-Derived; Glial Cell-Derived Neurotrophic Factor; Glial-Derived Neurotrophic Factor

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Intercellular Signaling Peptides and Proteins: 29768
    - Nerve Growth Factors: 5035
      - Glial Cell Line-Derived Neurotrophic Factors: 31
        Glial Cell Line-Derived Neurotrophic Factor: 2028
  - Nerve Tissue Proteins: 2
    - Nerve Growth Factors: 5035
      - Glial Cell Line-Derived Neurotrophic Factors: 31
        Glial Cell Line-Derived Neurotrophic Factor: 2028
- Peptides: 82426
  - Intercellular Signaling Peptides and Proteins: 29768
    - Nerve Growth Factors: 5035
      - Glial Cell Line-Derived Neurotrophic Factors: 31
        Glial Cell Line-Derived Neurotrophic Factor: 2028
Biological Factors: 2472
- Intercellular Signaling Peptides and Proteins: 29768
  - Nerve Growth Factors: 5035
    - Glial Cell Line-Derived Neurotrophic Factors: 31
      - Glial Cell Line-Derived Neurotrophic Factor: 2028

B Ruth Clark Selected Research

B Ruth Clark Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure